424 related articles for article (PubMed ID: 31335395)
1. Future Approaches to Precision Oncology-Based Clinical Trials.
Mittra A; Moscow JA
Cancer J; 2019; 25(4):300-304. PubMed ID: 31335395
[TBL] [Abstract][Full Text] [Related]
2. Challenges and approaches to implementing master/basket trials in oncology.
Burd A; Schilsky RL; Byrd JC; Levine RL; Papadimitrakopoulou VA; Herbst RS; Redman MW; Druker BJ; Gandara DR
Blood Adv; 2019 Jul; 3(14):2237-2243. PubMed ID: 31337605
[TBL] [Abstract][Full Text] [Related]
3. Basket Trials and the MD Anderson Precision Medicine Clinical Trials Platform.
Said R; Tsimberidou AM
Cancer J; 2019; 25(4):282-286. PubMed ID: 31335392
[TBL] [Abstract][Full Text] [Related]
4. Implementing Precision Medicine Programs and Clinical Trials in the Community-Based Oncology Practice: Barriers and Best Practices.
Ersek JL; Black LJ; Thompson MA; Kim ES
Am Soc Clin Oncol Educ Book; 2018 May; 38():188-196. PubMed ID: 30231363
[TBL] [Abstract][Full Text] [Related]
5. Community-driven development of a modified progression-free survival ratio for precision oncology.
Mock A; Heilig CE; Kreutzfeldt S; Huebschmann D; Heining C; Schröck E; Brors B; Stenzinger A; Jäger D; Schlenk R; Glimm H; Fröhling S; Horak P;
ESMO Open; 2019; 4(6):e000583. PubMed ID: 31798980
[TBL] [Abstract][Full Text] [Related]
6. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology.
Janiaud P; Serghiou S; Ioannidis JPA
Cancer Treat Rev; 2019 Feb; 73():20-30. PubMed ID: 30572165
[TBL] [Abstract][Full Text] [Related]
7. Ethical considerations of neuro-oncology trial design in the era of precision medicine.
Gupta S; Smith TR; Broekman ML
J Neurooncol; 2017 Aug; 134(1):1-7. PubMed ID: 28555425
[TBL] [Abstract][Full Text] [Related]
8. Current-day precision oncology: from cancer prevention, screening, drug development, and treatment - have we fallen short of the promise?
Morgan G; Aftimos P; Awada A
Curr Opin Oncol; 2016 Sep; 28(5):441-6. PubMed ID: 27428363
[TBL] [Abstract][Full Text] [Related]
9. Perspective on Precision Medicine in Oncology.
Johnson TM
Pharmacotherapy; 2017 Sep; 37(9):988-989. PubMed ID: 28632968
[TBL] [Abstract][Full Text] [Related]
10. Precision Medicine in Pediatric Oncology: Translating Genomic Discoveries into Optimized Therapies.
Tran TH; Shah AT; Loh ML
Clin Cancer Res; 2017 Sep; 23(18):5329-5338. PubMed ID: 28600472
[TBL] [Abstract][Full Text] [Related]
11. Innovation in oncology clinical trial design.
Verweij J; Hendriks HR; Zwierzina H;
Cancer Treat Rev; 2019 Mar; 74():15-20. PubMed ID: 30665053
[TBL] [Abstract][Full Text] [Related]
12. Precision Oncology Decision Support: Current Approaches and Strategies for the Future.
Kurnit KC; Dumbrava EEI; Litzenburger B; Khotskaya YB; Johnson AM; Yap TA; Rodon J; Zeng J; Shufean MA; Bailey AM; Sánchez NS; Holla V; Mendelsohn J; Shaw KM; Bernstam EV; Mills GB; Meric-Bernstam F
Clin Cancer Res; 2018 Jun; 24(12):2719-2731. PubMed ID: 29420224
[TBL] [Abstract][Full Text] [Related]
13. Clinical Trials in the Evolving Landscape of Precision Medicine.
Cancer Cell; 2020 Jul; 38(1):3-8. PubMed ID: 32663468
[TBL] [Abstract][Full Text] [Related]
14. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
[TBL] [Abstract][Full Text] [Related]
15. Biostatistical and Logistical Considerations in the Development of Basket and Umbrella Clinical Trials.
Yee LM; McShane LM; Freidlin B; Mooney MM; Korn EL
Cancer J; 2019; 25(4):254-263. PubMed ID: 31335389
[TBL] [Abstract][Full Text] [Related]
16. Personalized cancer therapy-leveraging a knowledge base for clinical decision-making.
Dumbrava EI; Meric-Bernstam F
Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29212833
[TBL] [Abstract][Full Text] [Related]
17. National Cancer Institute Basket/Umbrella Clinical Trials: MATCH, LungMAP, and Beyond.
Chen AP; Eljanne M; Harris L; Malik S; Seibel NL
Cancer J; 2019; 25(4):272-281. PubMed ID: 31335391
[TBL] [Abstract][Full Text] [Related]
18. Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment.
Schmidt KT; Chau CH; Price DK; Figg WD
J Clin Pharmacol; 2016 Dec; 56(12):1484-1499. PubMed ID: 27197880
[TBL] [Abstract][Full Text] [Related]
19. Defining, Identifying, and Understanding "Exceptional Responders" in Oncology Using the Tools of Precision Medicine.
Tsimberidou AM; Said R; Staudt LM; Conley BA; Takebe N
Cancer J; 2019; 25(4):296-299. PubMed ID: 31335394
[TBL] [Abstract][Full Text] [Related]
20. Art and Challenges of Precision Medicine: Interpreting and Integrating Genomic Data Into Clinical Practice.
Madhavan S; Subramaniam S; Brown TD; Chen JL
Am Soc Clin Oncol Educ Book; 2018 May; 38():546-553. PubMed ID: 30231369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
